Publications by authors named "Laura Catena"

Claim this Profile
R
Real-World Evaluation of the Management, Treatment Pathways and Outcome of Melanoma Patients with Target Therapies in Italy.
Ilaria Gioia Marcon, Diletta Valsecchi, Lorenza Durso, Eleonora Premoli, Diego Sangiorgi, Laura Catena

Adv Ther· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of Geriatric screening tool (G8) in predicting side effect in older patients during therapy with aromatase inhibitor.
Lorenzo Dottorini, Laura Catena, Italo Sarno, Giandomenico Di Menna, Annamaria Marte

J Geriatr Oncol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Everolimus in Combination with Octreotide Long-Acting Repeatable in a First-Line Setting for Patients with Neuroendocrine Tumors: A 5-Year Update.
Emilio Bajetta, Laura Catena, Sara Pusceddu, Francesca Spada, Claudio Iannacone

Neuroendocrinology· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues.
Sara Pusceddu, Claudio Vernieri, Massimo Di Maio, Riccardo Marconcini, Francesca Spada, Laura Catena

Gastroenterology· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Lasting Exceptional Radiological Complete Response after Treatment with Eribulin in a Patient with Triple-Negative Breast Cancer with Liver Involvement.
Lorenzo Dottorini, Laura Catena, Italo Sarno, Giandomenico Di Menna, Annamaria Marte

Oncology· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors.
Sara Pusceddu, Francesco Barretta, Annalisa Trama, Laura Botta, Massimo Milione, Laura Catena

Endocr Relat Cancer· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sunitinib in patients with pre-treated pancreatic neuroendocrine tumors: A real-world study.
Maria Rinzivillo, Nicola Fazio, Sara Pusceddu, Andrea Spallanzani, Toni Ibrahim, Laura Catena

Pancreatology· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of a three-drug combination including cisplatin (CLOVER regimen) for poorly differentiated neuroendocrine carcinoma.
Emilio Bajetta, Laura Catena, Pamela Biondani, Sara Pusceddu, Monica Valente

Anticancer Res· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Everolimus in combination with octreotide long-acting repeatable in a first-line setting for patients with neuroendocrine tumors: an ITMO group study.
Emilio Bajetta, Laura Catena, Nicola Fazio, Sara Pusceddu, Pamela Biondani

Cancer· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New perspectives in the treatment of neuroendocrine tumours.
Emilio Bajetta, Laura Catena, Monica Valente, Nadia Bianco, Fernanda Bellomo

Anticancer Res· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuroendocrine tumors of unknown primary site: gold dust or misdiagnosed neoplasms?
Laura Catena, Ettore Bichisao, Massimo Milione, Monica Valente, Marco Platania

Tumori· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mammalian target of rapamycin expression in poorly differentiated endocrine carcinoma: clinical and therapeutic future challenges.
Laura Catena, Emilio Bajetta, Massimo Milione, Monika Ducceschi, Monica Valente

Target Oncol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perspectives in the development of novel treatment approaches.
James C Yao, Laura Catena, Annamaria Colao, Giovanni Paganelli

Tumori· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Common Diagnostic Challenges in the Histopathologic Diagnosis of Neuroendocrine Lung Tumors: A Case Report.
Monica Valente, Laura Catena, Massimo Milione, Sara Pusceddu, Barbara Formisano

Case Rep Oncol· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pitfalls in the diagnosis of neuroendocrine tumors: atypical clinical and radiological findings as cause of medical mistakes.
Emilio Bajetta, Laura Catena, Monika Ducceschi, Sara Pusceddu, Massimo Milione

Tumori· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of antithrombotic prophylaxis on infectious complications in cancer patients with central venous catheters: an observational study.
Daniele Fagnani, Alessandro Bertolini, Laura Catena, Maurizio Tomirotti, Marilena Visini

Blood Coagul Fibrinolysis· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary carcinoid tumours: indolent but not benign.
Sara De Dosso, Emilio Bajetta, Giuseppe Procopio, Diego Cortinovis, Roberto Buzzoni, Laura Catena

Oncology· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and activity of sorafenib in different histotypes of advanced renal cell carcinoma.
Giuseppe Procopio, Elena Verzoni, Arpine Gevorgyan, Maddalena Mancin, Sara Pusceddu, Laura Catena

Oncology· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Merkel cell carcinoma after liver transplantation: a case report.
Emilio Bajetta, Marco Platania, Laura Catena, Ettore Bichisao, Alessandra Fabbri

Tumori· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal cell cancer and sorafenib: skin toxicity and treatment outcome.
Emilio Bajetta, Giuseppe Procopio, Elena Verzoni, Laura Catena, Sara De Dosso

Tumori· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are capecitabine and oxaliplatin (XELOX) suitable treatments for progressing low-grade and high-grade neuroendocrine tumours?
Emilio Bajetta, Laura Catena, Giuseppe Procopio, Sara De Dosso, Ettore Bichisao

Cancer Chemother Pharmacol· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kit protein (CD117) and proliferation index (Ki-67) evaluation in well and poorly differentiated neuroendocrine tumors.
Leonardo Ferrari, Silvia Della Torre, Paola Collini, Antonia Martinetti, Giuseppe Procopio, Laura Catena

Tumori· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lanreotide autogel every 6 weeks compared with Lanreotide microparticles every 3 weeks in patients with well differentiated neuroendocrine tumors: a Phase III Study.
Emilio Bajetta, Giuseppe Procopio, Laura Catena, Antonia Martinetti, Sara De Dosso

Cancer· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuroendocrine tumors of the larynx: a clinical report and literature review.
Giuseppe Procopio, Riccardo Ricotta, Alberto Fusi, Luigi Celio, Sara De Dosso, Laura Catena

Tumori· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report of synchronous multicentric osteosarcoma and review of the literature: the importance of autopsy for diagnosis.
Roberto Buzzoni, Silvia Della Torre, Diego Cortinovis, Laura Catena

Tumori· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis